Bml 277 , CHK2 kinase inhibitor
-
Catalog number
SIH-436-50MG
-
Price
Please ask
-
Size
50 mg
-
-
Stock availabilitIn Stock
In Stock
-
CAS number
516480-79-8
-
Description
CHK2 kinase inhibitor
-
Molecular weight
363,8 g/mol
-
Primary research fields
Cell Signaling, Cancer, Apoptosis, Cancer Growth Inhibitors, Tyrosine Kinase Inhibitors
-
Other name
Chk2 Inhibitor II, Chk2 Inhibitor II hydrate, 2-(4-(4-Chlorophenoxy)phenyl)-1H-benzimidazole-5-carboxamide hydrate
-
Product category
Small Molecules
-
Product type
Inhibitor
-
Chemical formula
C20H14ClN3O2
-
Origin
Synthetic
-
Purity pourcentage
≥98% (TLC)
-
Soluble in
Soluble in DMSO (20 mg/ml) or ethanol (20 mg/ml)
-
Physical appearance
Off-white solid
-
Storage recommendations
-20ºC
-
Shipping recommendations
Shipped Ambient
-
Safety information
Classification: Not a hazardous substance or mixture. Safety Phrases: S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
-
PubChem number
9969021
-
Scientific context
Bml 277 is a highly selective inhibitor of Chk2, making it a useful tool for dissecting the role of Chk2 in cellular signaling.
-
Bibliography
1. Pereg Y., et al. (2006) Mol. Cell Biol. 26(18): 6819–6831.
-
Release date
1-Oct-2014
-
PubMed number
Refer to PubMed
-
Tested applications
To be tested
-
Tested reactivity
To be tested
-
-
Representative figure legend
Chemical structure of BML 277 (SIH-436), a CHK2 kinase inhibitor. CAS #: 516480-79-8. Molecular Formula: C20H14ClN3O2. Molecular Weight: 363.8 g/mol. Chemical structure of BML 277 , a CHK2 kinase inhibitor (SIH-436). CAS # 516480-79-8. Molecular Formula: C20H14ClN3O2.
-
Warning information
Non-hazardous
-
Country of production
Canada
-
Total weight kg
0.25
-
Net weight g
0.05
-
-
Additional description
Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
-
Gene target
-
Gene symbol
CHEK2
-
Short name
Bml 277 , CHK2 kinase inhibitor
-
Alternative name
Bml 277 , CHK2 phosphorylation catalyst suppressor
-
Gene info
-
Identity
-
Gene
-
Long gene name
checkpoint kinase 2
-
Synonyms gene
-
Synonyms gene name
- CHK2 (checkpoint, S.pombe) homolog
- CHK2 checkpoint homolog (S. pombe)
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year
2001-09-19
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
VEGA ID
-
Locus Specific Databases
Similar products